Search Results for: weekly reads

Weekly reads: aging, CRISPR delivery, hair, oocytes, paralysis

CRISPR-Model-Jacob-Corn-e1464305007640

The big news of the week was the launch of Altos labs and their ambitious plan to tackle aging through cell therapies. Altos has recruited a large number of top cell biologists away from academia. That team plus top biotech execs and a $3B war chest make Altos one to watch in coming years. I …

Weekly reads: aging, CRISPR delivery, hair, oocytes, paralysis Read More »

Weekly reads: hydra heads, iblastoids, new 8-year grants

Grant writers handbook, grants cartoon

What if you could get 8-year grants to do whatever biomedical research you wanted? This sounds like a dream for many of us in the life sciences, but the first news item this week is all about such a potential new funding approach. The item especially caught my eye as I’m going to be doing …

Weekly reads: hydra heads, iblastoids, new 8-year grants Read More »

Weekly reads: PRC2, 2 weird bits of news, pubs, COVID stem cell hype

PRC2 lineage commitment

I’d say the paper of the week is on how PRC2 mediated H3K27me3 can in some sense replace elements of DNA methylation to repress. Very cool. Here it is: Sex-specific chromatin remodelling safeguards transcription in germ cells, Nature. Weird stuff In a merger of opposites, City of Hope to buy Cancer Treatment Centers of America …

Weekly reads: PRC2, 2 weird bits of news, pubs, COVID stem cell hype Read More »

Weekly reads: grad student life, cell barcoding, diabetes trial, more

ViaCyte capsule stem cells diabetes

Part of being a grad student is dealing with technologies related to your projects and their limitations. Sometimes I feel old when I remember the way we used to have to do things in the lab. As a grad student, I manually poured, ran, and read giant sequencing gels. Back then, gene synthesis of a …

Weekly reads: grad student life, cell barcoding, diabetes trial, more Read More »

Weekly reads: R01 grant trends, DPPA4, adult human neurogenesis debate

NIH R01 grant trends

Great ideas and talented scientists are not enough as biomedical research needs funding and here in the U.S. that means having R01 grant success. The trends since 1995 are slowly heading the wrong way. The average age of getting your first R01 grant keeps getting older. There is also still a bit of a possible …

Weekly reads: R01 grant trends, DPPA4, adult human neurogenesis debate Read More »

Weekly reads: New FDA guidance, brains, MSCs, senescence

human mouse marmoset brain

This week marked the release of new draft FDA guidance on cell and gene therapies. Is the FDA kind of like the guidance counselor at school or more like the principal? It probably depends on many factors. I also find it funny how pretty much everyone in academia and biotech industry works to be compliant …

Weekly reads: New FDA guidance, brains, MSCs, senescence Read More »

Weekly reads: news, legos for stem cells, FDA, cancer, more

Legos for stem cells Fig 1b

I’ve been busy recently focusing more on grant and paper writing than reading papers on stem cells, but my piece on trying to de-extinct mammoths via cloning-like methods drew strong opinions on both sides. Recent news and resources on stem cells We’re still awaiting a verdict in the big California federal court case where the FDA is …

Weekly reads: news, legos for stem cells, FDA, cancer, more Read More »

Weekly reads: Bezos & stem cells for anti-aging, Myc, more

young blood, stem cells anti-aging

Stem cells may have anti-aging properties, but they are unlikely to be a real fountain of youth. Even so, people are obsessed with aging and stem cells regularly are thought of as “the ticket” for fighting aging. I’ll start today’s recommended reads with that topic and then go on to list some interesting papers of …

Weekly reads: Bezos & stem cells for anti-aging, Myc, more Read More »